Obstructive Sleep Apnea
Fixed continuous positive airway pressure for the treatment of obstructive sleep apnea was associated with preventing a time-dependent decline in estimated glomerular filtration rate.
Portable sleep monitoring may accurately diagnose sleep apnea in patients who are hospitalized with heart failure.
The mean extracranial zygoma thickness was the same for those with and without obstructive sleep apnea.
Continuous positive airway pressure (CPAP) remains the mainstay of medical treatment for OSA.
Sleep quality in patients with chronic obstructive pulmonary disease may be a significant predictor of multiple metrics of quality of life.
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Pediatric patients with hypertension and obstructive sleep apnea had significant improvements in blood pressure after adenotonsillectomy.
Severe sleep disordered breathing was associated with elevated arterial stiffness and may be related to the pathophysiology of heart failure, particularly in patients with preserved ejection fraction.
Patients with obstructive sleep apnea had higher rates of hospital readmission when not adherent to continuous positive airway pressure therapy.
Prior authorizations for medications and diagnostic imaging continue to be a source of frustration for providers.
Oronasal masks may not be as effective as nasal masks for the treatment of obstructive sleep apnea.
Non-sleep specialists and sleep specialist physicians provide similar quality care with similar patient outcomes for adults with OSA.
Patients with sleep apnea may have a higher risk for recurrent stroke and death.
A new 14-year analysis indicate that adults are getting more sleep each night despite the prevalence of sleep duration among Americans.
A middle-aged man diagnosed with COPD presents with shortness of breath at rest with no improvement with nebulizer treatments.
Moderate to severe obstructive sleep apnea is relatively common in individuals with major depression.
Dronabinol may be an effective treatment in adults with obstructive sleep apnea.
Bariatric surgery and continuous positive airway pressure were directly compared as initial treatment modalities for obstructive sleep apnea.
Home sleep apnea tests are a less expensive alternative to polysomnography tests in detecting obstructive sleep apnea.
Patients with severe obstructive sleep apnea who use continuous positive airway pressure therapy may experience a decrease in carotid intima-media thickness.
Participants received web-based OSA education, CPAP telemonitoring with automated feedback, both, or usual care.
Patients identified as having high-risk obstructive sleep apnea by the STOP-Bang Questionnaire were more likely to have postoperative complications and longer hospital stays.
Patients with severe obstructive sleep apnea appear to have a higher risk for hypercoagulability, which can contribute to cardiovascular complications.
The automatically estimated apnea-hypopnea index showed high agreement with AHI measured with conventional nocturnal polysomnography.
Adverse events and renal function were monitored in patients receiving CPAP and those receiving usual care.
In patients with mild cognitive impairment, there is an association between obstructive sleep apnea and beta-amyloid levels.
Watching a tape of themselves struggling to sleep increases CPAP adherence in patients with OSA.
Researchers simultaneously examined overnight polysomnography and patch recordings to determine the efficacy of the SomnaPatch.
A patient developed Stevens-Johnson Syndrome following armodafinil therapy for daytime sleepiness.
Research presented at SLEEP 2017 suggests that dronabinol, previously used to treat chemotherapy-induced nausea and vomiting, may be an effective treatment for sleep apnea.